APA (7th ed.) Citation

Bouattour, N., Hdiji, O., Sakka, S., Fakhfakh, E., Moalla, K., Daoud, S., . . . Mhiri, C. (2022). Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: Case report and review of reported cases. Neurological Sciences, 43(2), 755. https://doi.org/10.1007/s10072-021-05733-x

Chicago Style (17th ed.) Citation

Bouattour, Nadia, Olfa Hdiji, Salma Sakka, Emna Fakhfakh, Khadija Moalla, Sawsan Daoud, Nouha Farhat, Mariem Damak, and Chokri Mhiri. "Guillain-Barré Syndrome Following the First Dose of Pfizer-BioNTech COVID-19 Vaccine: Case Report and Review of Reported Cases." Neurological Sciences 43, no. 2 (2022): 755. https://doi.org/10.1007/s10072-021-05733-x.

MLA (9th ed.) Citation

Bouattour, Nadia, et al. "Guillain-Barré Syndrome Following the First Dose of Pfizer-BioNTech COVID-19 Vaccine: Case Report and Review of Reported Cases." Neurological Sciences, vol. 43, no. 2, 2022, p. 755, https://doi.org/10.1007/s10072-021-05733-x.